Skip to content

Clinical research of central combined with peripheral nerve magnetic stimulation on motor function rehabilitation in patients with ischemic stroke

Clinical research of central combined with peripheral nerve magnetic stimulation on motor function rehabilitation in patients with ischemic stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052075
Enrollment
Unknown
Registered
2021-10-16
Start date
2021-10-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Conventional rehabilitation group:On the basis of conventional treatment, the contralateral cerebral cortex was given sham stimulation
Single target stimulation group:On the basis of conventional rehabilitation, the contralateral cerebral cortex was given stimulation
Dual target stimulation group:On the basis of single target stimulation, Erbs point magnetic stimulation was added

Sponsors

Shanghai Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as stroke by clinical evaluation and comprehensive imaging examination meet the diagnostic criteria formulated by the 2014 National Cerebrovascular Academic Conference; 2. Fugl-Meyer motor function score proved to be motor dysfunction, and > 1 point in the combined movement evaluation project; 3. Aged 18-70 years, male or female; 4. No cognitive impairment or communication impairment, simple mental state examination (MMSE) more than 27 points; 5. The first onset, and the course of disease is from 2 days to 6 months.

Exclusion criteria

Exclusion criteria: 1. Those who have serious systemic diseases such as cardiopulmonary diseases and cannot tolerate rehabilitation treatment; 2. Patients diagnosed with psychosis, severe depression (suicidal tendency) or epilepsy, and family history of psychosis or epilepsy; 3. Patients with serious systemic diseases such as diabetes and uremia; 4. Patients with severe joint contracture; 5. Patients suffering from disturbance of consciousness for any reason; 6. According to the safety guidelines, there are contraindications for transcranial direct current/magnetic stimulation (TMS/tDCS) and functional magnetic resonance (fMRI), such as metal foreign bodies in the body or other electronic devices implanted in the body; 7. Hearing or visual defects may affect the evaluation and treatment; 8. Using drugs that change the excitability of cerebral cortex (antiepileptic drugs, sedative and hypnotic drugs, etc.).

Design outcomes

Primary

MeasureTime frame
Fugl Meyer motor assessment(FMA);

Secondary

MeasureTime frame
MAS(Modified Ashworth Scale);MMT(Manual Muscle Test);Modified Barthel Index(MBI);Hand function assessment;Neuroelectrophysiological feedback and detection;fMRI(functional magnetic resonance imaging) brain function;fNIRS(functional near - infrared spectroscopy);EEG (electroencephalogram, resting EEG and evoked EEG);

Countries

China

Contacts

Public ContactChen Yuhui

Shanghai Tongji Hospital

zgyedu@sina.cn+86 16602103404

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026